Tom Coll

Tom Coll

Dec 7, 2020

Tom Coll is a partner at Cooley LLP. His practice covers a broad range of general corporate matters, including counseling public and privately held companies regarding disclosure and reporting requirements, technology licensing, equity incentives, employee...
Richard Daniels

Richard Daniels

Feb 4, 2021

Richard Daniels has 30+ years of experience in the pharmaceutical industry spanning all phases of drug development and commercialization. He is currently Managing Director at Halloran Consulting, which provides preclinical, clinical, regulatory and quality services to...
Matthew W. McClure, MD

Matthew W. McClure, MD

Oct 8, 2024

Dr. McClure is a consulting Chief Medical Officer (CMO) of Primmune Therapeutics. Dr. McClure has been a CMO at multiple companies over the past nearly seven years and has more than 20 years of clinical and drug development experience with significant expertise in the...
Melissa Palmer, MD

Melissa Palmer, MD

Oct 8, 2024

Dr. Palmer is an internationally renowned hepatologist and an experienced biotech/pharma executive. She is currently CEO Liver Consulting LLC, where she provides insight to the biotech and pharmaceutical industry fostering a path forward for the development of...
Elina Zuniga, PhD

Elina Zuniga, PhD

Jan 13, 2021

Dr. Elina I. Zúñiga is currently Full Professor at the Division of Biological Sciences, University of California San Diego (UCSD), La Jolla, CA. She was honored with the highest recognition for best academic performance during her undergraduate education at the...